New York lawmakers won't pass a 340B drug program protection bill this session, disappointing hospitals and health centers ...

This appeal concerns Maine's effort to use state law to impose additional obligations on drug manufacturers who participate ...

CVS Faces Lawsuit for Allegedly Pocketing $250 Million in Drug Savings Meant for Uninsured Patients ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

An initiative to expand a federal program that provides drug discounts to hospitals and clinics in Illinois has been met with pushback as it nears passage. Opponents have said the program doesn’t ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Mere days before the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program’s (“Pilot”) scheduled January 1, 2026 effective date, a federal district court granted a ...

The alleged fraud scheme deprived Mount Sinai of crucial funds meant for vulnerable, uninsured New Yorkers, claims the suit, ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...

Despite strong support from safety-net providers, advocates and legislative champions, protections for the federal 340B Drug Pricing Program were not included in the final state budget. With the end ...

FOX Business' Gerri Willis reports on health care abuse accusations against the federal 340B drug program and the impact of costs on 'Varney & Co.' ...